CHAPEL HILL, N.C., Sept. 21, 2011 /PRNewswire/ -- Pharmaceutical and biotechnology organizations use health outcomes data to support a variety of product-related initiatives, from treatment guidelines to formulary decisions. With health outcomes data playing such a pivotal role in a product's performance, it's important for organizations to optimize the use of Health Outcomes data.
To help organizations understand current approaches to effectively using health outcomes data in the marketplace, Best Practices, LLC has published a study that examines the internal and external uses of Health Outcomes data for promotional and strategic purposes.
The study, Best Practices in Utilizing Health Outcomes Data, provides comparative data from 2009 and 2011 that illustrate shifting attitudes for how organizations utilize health outcomes data.
Organizations in 2011 used health outcomes data internally mostly for determining market access and scientific publication strategies. Relative to 2009, the importance of using health outcomes data internally for reimbursement decisions increased 24 percent, from 45 percent in 2009 to 69 percent in 2011, according to the study. Meanwhile, in 2011 and 2009, reimbursement and drug formulary decisions were the main use of health outcomes data for interactions with managed care, according to the study.
The 51-page study reflects current approaches to health outcomes data utilization at 16 biopharma organizations; the 2009 data is based on a benchmark class of 29 companies.
The insights in this new study will help pharmaceutical and biotech organizations compare their use of health outcomes data in promotional and internal settings with that of leading organizations. The study also examines the pressing regulatory issues raised by the different uses of health outcomes data.
Key topics covered in this research include:
To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1119.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a research and consulting firm that has served many of the world's 50 top pharmaceutical companies. For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information about the company, go to www.best-in-class.com.
|SOURCE Best Practices, LLC|
Copyright©2010 PR Newswire.
All rights reserved